XOMA Competitors & Alternatives
Compare XOMA Royalty Corporation with similar stocks in the same industry
Biotechnology
XOMA
Main Stock$40.17
-9.16%
Tradestie Score
46
Market Cap
$474.20M
P/E Ratio
28.2
Revenue Growth
-22.6%
Analyst Upside
-2.9%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Other
Biotech Royalties
Major Customers
3
biotech and pharma partners
Novartis
various development-stage companies
Critical Suppliers
0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals
1
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KOD
Kodiak Sciences Inc Common Stock
|
$103.51
-6.91%
|
$832.47M | - | 39 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$28.01
+6.99%
|
$824.20M | - | 61 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.34
-9.38%
|
$821.84M | - | 40 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$53.69
-4.02%
|
$800.41M | - | 45 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$7.63
-1.71%
|
$799.70M | - | 68 | Compare |
|
KURA
Kura Oncology, Inc.
|
$7.30
-6.05%
|
$798.53M | - | 63 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$9.76
-2.01%
|
$791.82M | - | 35 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$7.15
-5.42%
|
$757.72M | - | 33 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$11.86
-8.84%
|
$748.90M | - | 45 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
More XOMA Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry